🇯🇵 Mulpleta in Japan

PMDA authorised Mulpleta on 28 September 2015

Marketing authorisations

PMDA — authorised 28 September 2015

  • Status: approved

Mulpleta in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Cardiovascular approved in Japan

Frequently asked questions

Is Mulpleta approved in Japan?

Yes. PMDA authorised it on 28 September 2015; PMDA has authorised it.

Who is the marketing authorisation holder for Mulpleta in Japan?

Vancocin Italia is the originator. The local marketing authorisation holder may differ — check the official source linked above.